Brandi Binkley

Ms. Brandi Binkley

West Virginia University, Morgantown, West Virginia, USA
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 March 2025 in Analytical Chemistry
Verified
Journal Article
Open access
TGToktam Godary
Toktam Godary
BBBrandi Binkley
Brandi Binkley
ZLZhengru Liu
Zhengru Liu
OAOlanrewaju Awoyemi
Olanrewaju Awoyemi
AOAmanda Overby
Amanda Overby
PLPeng Li
Peng Li

23 August 2022 in Biosensors
Verified
Journal Article
Open access
PDF file
KCKathrine Curtin
Kathrine Curtin
BFBethany Joy Fike
Bethany Joy Fike
BBBrandi Binkley
Brandi Binkley
TGToktam Godary
Toktam Godary
PLPeng Li
Peng Li
Digital biosensing assays demonstrate remarkable advantages over conventional biosensing systems because of their ability to achieve single-molecule detection and absolute quantification. Unlike traditional low-abundance biomarking screening, digital-based biosensing systems reduce sample volumes significantly to the fL-nL level, which vastly reduces overall reagent consumption, improves reaction time and throughput, and enables high sensitivity and single target detection. This review presents the current technology for compartmentalizing reactions and their applications in detecting proteins and nucleic acids. We also analyze existing challenges and future opportunities associated with digital biosensing and research opportunities for developing integrated digital biosensing systems.

25 March 2025 in Biosensors
Verified
Journal Article
Open access
PDF file
BBBrandi Binkley
Brandi Binkley
PLPeng Li
Peng Li
3D-printed microdevices have become increasingly important to the advancement of point-of-care (POC) immunoassays. Despite its great potential, using 3D-printed surfaces on the solid support for immunorecognition has been limited due to the non-ideal adsorption properties for many photocurable resins. In this work, we report a simple surface modification protocol that works for diverse commercial photocurable resins, improving ELISAs performed directly on 3D-printed devices. This surface modification strategy involves surface activation via air plasma followed by the one-step incubation of GLYMO-labeled streptavidin. We successfully immobilized biotinylated anti-activin A antibodies on the 3D-printed surfaces and performed the complete ELISA protocol on the 3D-printed surfaces. We demonstrated that this protocol achieved an improved performance over passive adsorption for ELISAs. The present method is also compatible with diverse commercial resins and works with both microwells and microchannels. Finally, this method demonstrated a comparable limit of detection to the ELISA performed using commercial microwells. We believe the simplicity and broad compatibility of the present surface modification strategy will facilitate the development of 3D-printed POC ELISA devices.